Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Clinical trial data from SURMOUNT-1 shows that the 2.5 mg dose produces minimal weight reduction on its own, which is expected since this dose is specifically labeled as an initiation dose rather than a maintenance dose
These findings are virtually identical to the results of the STEP 1 trial for the 2.4 mg injectable semaglutide, which reported a 14.9%-16% weight reduction over a similar period
Retatrutide 12mg 61,231 Verified COA Available Free BAC Water Included in every order You don't need to add it
Macular complications Although uncommon, some cases of macular edema have been reported while taking GLP-1 receptor agonists, such as semaglutide
